141 related articles for article (PubMed ID: 11323020)
1. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients.
Ouviña SM; La Greca RD; Zanaro NL; Palmer L; Sassetti B
Thromb Res; 2001 Apr; 102(2):107-14. PubMed ID: 11323020
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
3. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
4. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
5. Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
Bhatia GS; Sosin MD; Patel JV; Grindulis KA; Khattak FH; Davis RC; Lip GY
Int J Cardiol; 2009 May; 134(1):97-103. PubMed ID: 18501982
[TBL] [Abstract][Full Text] [Related]
6. Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
Freestone B; Chong AY; Nuttall S; Blann AD; Lip GY
Chest; 2007 Oct; 132(4):1253-8. PubMed ID: 17890461
[TBL] [Abstract][Full Text] [Related]
7. [Endothelial immune activation and functional state in patients with hypertensive disease].
Ashcheulova TV; Kovalyova ON; Gerasimchuk NN
Ter Arkh; 2017; 89(9):20-24. PubMed ID: 29039826
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension.
Woodman RJ; Watts GF; Puddey IB; Burke V; Mori TA; Hodgson JM; Beilin LJ
Atherosclerosis; 2002 Jul; 163(1):175-81. PubMed ID: 12048137
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor in diabetic angiopathy.
Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.
Genc H; Dogru T; Tapan S; Tasci I; Bozoglu E; Gok M; Aslan F; Celebi G; Erdem G; Avcu F; Ural AU; Sonmez A
Clin Biochem; 2012 Jan; 45(1-2):92-5. PubMed ID: 22100896
[TBL] [Abstract][Full Text] [Related]
11. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
Caballero AE; Arora S; Saouaf R; Lim SC; Smakowski P; Park JY; King GL; LoGerfo FW; Horton ES; Veves A
Diabetes; 1999 Sep; 48(9):1856-62. PubMed ID: 10480619
[TBL] [Abstract][Full Text] [Related]
12. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
13. Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease.
Lavallée PC; Labreuche J; Faille D; Huisse MG; Nicaise-Roland P; Dehoux M; Gongora-Rivera F; Jaramillo A; Brenner D; Deplanque D; Klein IF; Touboul PJ; Vicaut E; Ajzenberg N;
Cerebrovasc Dis; 2013; 36(2):131-8. PubMed ID: 24029712
[TBL] [Abstract][Full Text] [Related]
14. Indices of thrombogenesis, endothelial damage and platelet function following percutaneous peripheral artery angiography and angioplasty for peripheral vascular disease.
Makin AJ; Chung NA; Silverman SH; Moss MS; Lip GY
Pathophysiol Haemost Thromb; 2003; 33(2):102-8. PubMed ID: 14624052
[TBL] [Abstract][Full Text] [Related]
15. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
van Etten RW; de Koning EJ; Verhaar MC; Gaillard CA; Rabelink TJ
Diabetologia; 2002 Jul; 45(7):1004-10. PubMed ID: 12136399
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
Lip GY; Edmunds E; Hee FL; Blann AD; Beevers DG
Am J Hypertens; 2001 Aug; 14(8 Pt 1):823-8. PubMed ID: 11497201
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Spencer CG; Gurney D; Blann AD; Beevers DG; Lip GY;
Hypertension; 2002 Jul; 40(1):61-6. PubMed ID: 12105139
[TBL] [Abstract][Full Text] [Related]
18. Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease.
Chen J; Hamm LL; Mohler ER; Hudaihed A; Arora R; Chen CS; Liu Y; Browne G; Mills KT; Kleinpeter MA; Simon EE; Rifai N; Klag MJ; He J
PLoS One; 2015; 10(7):e0132047. PubMed ID: 26132137
[TBL] [Abstract][Full Text] [Related]
19. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.
Yu Y; Suo L; Yu H; Wang C; Tang H
Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
